Dr. Carl Sanders

Carl is a partner in the firm’s German private capital practice. He advises private equity houses and financial sponsor clients on their M&A deals, strategic investments and joint ventures.

Carl also advises sponsors on the management of their existing portfolio companies, including on management investment plans, equity financings, liquidity events and add-on transactions.

Carl regularly works on complex cross-border transactions and has gained first-hand insights having spent six months as a secondee with a financial sponsor client.

Recently, Carl has been recognised by JUVE as one of the most influential “40 under 40” lawyers in Corporate law in Germany.

Work highlights

Carl’s recent experience includes advising:

• GTCR on the bidding process regarding the acquisition of GGW from hg
• Macquarie on

the sale of Macquarie’s Real Estate Fund Management Platform GLL Real Estate Partners

the bidding process regarding a stake in EWE AG alongside Allianz Capital Partners

• Apax Partners on 

the acquisition of Rodenstock

the acquisition of neuraxpharm

• Allianz Capital Partners on 

the acquisition of a 18% stake in ATC Europe from American Tower

its investment in Austrian fibre network company öGIG

• iCON Infrastructure on its acquisition of Alliance Medical from Life Healthcare
• Montagu Private Equity on 

its acquisition of Waystone and several add-on acquisitions

its acquisition of Universal Investment, several add-on acquisitions in Germany, Luxembourg and Ireland, as well as several minority divestments, including on the sale of a substantial minority interest to CPPIB

Carl has studied law at the University of Freiburg and at the University of Cambridge. He holds a PhD from the University of Mannheim.

He speaks German and English.